Talphera reaches 50% enrollment in NEPHRO-CRRT registrational trial Mar 2, 2026 08:31AM
Talphera reaches 17-patient enrollment in NEPHRO CRRT pivotal trial Aug 25, 2025 08:31AM
H.C. Wainwright Reiterates Buy Rating on Talphera (TLPH) Apr 1, 2025 06:48AM
Talphera (TLPH) Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Mar 31, 2025 08:30AM
Rodman & Renshaw Starts Talphera (TLPH) at Buy Jan 28, 2025 06:43AM


Jan 14, 2025 08:35AM Talphera (TLPH) Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
Aug 19, 2024 08:32AM Talphera (TLPH) Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit